1 year return (CAGR)
-1.74%
Zenas BioPharma, Inc. Common Stock Exchange (NASDAQ, USD)
ZBIO
27.30
+0.54 (+2.17%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.66B
Price/Sales
150.50
Ent value
1.91B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 24.96 |
| Daily high | 25.94 |
| Daily low | 24.26 |
| Daily Volume | 472K |
| All-time high | 43.17 |
| 1y analyst estimate | 47.88 |
| Beta | -1.02 |
| EPS (TTM) | -7.67 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ZBIO | S&P500 | |
| Current price drop from All-time high | -36.76% | -1.21% |
| Highest price drop | -74.96% | -56.47% |
| Date of highest drop | 19 Feb 2025 | 9 Mar 2009 |
| Avg drop from high | -41.06% | -10.65% |
| Avg time to new high | 21 days | 12 days |
| Max time to new high | 240 days | 1805 days |
News
